Patients with pre-existing cardiovascular risk factors should be monitored appropriately when initiating tirzepatide therapy, particularly during dose escalation when gastrointestinal effects are most pronounced
Reduction of the butyrate concentration in IBS patients may cause energy salvage in the colon and IBS symptoms (Farup et al., 2016)
CrossRef Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease Jung Hwan Yu The Korean Journal of Medicine .2024
Acta Physiol Plant 42(10):159 Charlton AJ, Donarski JA, Harrison M, Jones SA, Godward J, Oehlschlager S et al (2008) Responses of the pea ( Pisum sativum L.) leaf metabolome to drought stress assessed by nuclear magnetic resonance spectroscopy
The magnitude of the increase in liver size is dependent upon the specific xenobiotic, the magnitude of the dose, and the frequency of dosing
But should you try it for yourself